Trump has demanded that pharma companies move production to the US

U.S. President Donald Trump warned drug manufacturers about future tariffs and said that they should accelerate the relocation of production in the United States if they do not want to face duties. This is reported on February 21 Bloomberg with reference to the interlocutors.

It is noted that the meeting was held on Thursday with company executives, including the chief executive officer of Eli Lilly & Co. David Ricks, CEO of Merck & Co. Robert Davis and CEO of Pfizer Inc. Albert Burla.

The agency reports that the U.S. leader did not try to ask Congress to soften the drug pricing program, which began under former President Joe Biden and which pharma companies have been trying to get rid of.

Empire strikes back: US to impose duties on the rest of the world

Duties will be set according to criteria to be established in Washington, DC

Earlier, on February 1, Trump signed an executive order imposing trade tariffs of 25% on goods from Canada, China and Mexico. Then he also promised to impose duties on goods from the EU. On February 10, it was reported that Trump raised tariffs on imports of steel and aluminum from 10% to 25%, and also removed various exemptions and quotas on duty waivers for the largest suppliers.